{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T02:34:23Z","timestamp":1696646063880},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,7,6]],"date-time":"2014-07-06T00:00:00Z","timestamp":1404604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13318-014-0215-8","type":"journal-article","created":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T09:24:33Z","timestamp":1404552273000},"page":"389-399","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetic drug\u2013drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate"],"prefix":"10.1007","volume":"40","author":[{"given":"Julia","family":"Winkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Goldammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Zurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,6]]},"reference":[{"key":"215_CR1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2125.2010.03845.x","volume":"71","author":"R Abbas","year":"2011","unstructured":"Abbas R, Hug BA, Leister C, Burns J, Sonnichsen D (2011) Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects. Br J Clin Pharmacol 71:522\u2013527. doi: 10.1111\/j.1365-2125.2010.03845.x","journal-title":"Br J Clin Pharmacol"},{"key":"215_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13625180400017776","volume":"9","author":"E Aubeny","year":"2004","unstructured":"Aubeny E, Buhler M, Colau JC, Vicaut E, Zadikian M, Childs M (2004) The Coraliance study: non-compliant behavior. Results after a 6-month follow-up of patients on oral contraceptives. Eur J Contracept Reprod Health Care 9:267\u2013277","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"215_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1701-2163(16)30692-2","volume":"26","author":"AR Baerwald","year":"2004","unstructured":"Baerwald AR, Pierson RA (2004) Ovarian follicular development during the use of oral contraception: a review. J Obstet Gynaecol Can 26:19\u201324","journal-title":"J Obstet Gynaecol Can"},{"key":"215_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.contraception.2005.06.057","volume":"73","author":"IC Barbosa","year":"2006","unstructured":"Barbosa IC, Filho CI, Faggion D Jr, Baracat EC (2006) Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). Contraception 73:30\u201333. doi: 10.1016\/j.contraception.2005.06.057","journal-title":"Contraception"},{"issue":"134","key":"215_CR5","first-page":"e131","volume":"197","author":"RT Burkman","year":"2007","unstructured":"Burkman RT (2007) Transdermal hormonal contraception: benefits and risks. Am J Obstet Gynecol 197(134):e131\u2013e136. doi: 10.1016\/j.ajog.2007.04.027","journal-title":"Am J Obstet Gynecol"},{"key":"215_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.maturitas.2003.11.009","volume":"47","author":"HJ Coelingh Bennink","year":"2004","unstructured":"Coelingh Bennink HJ (2004) Are all estrogens the same? Maturitas 47:269\u2013275. doi: 10.1016\/j.maturitas.2003.11.009","journal-title":"Maturitas"},{"key":"215_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","volume":"38","author":"GK Dresser","year":"2000","unstructured":"Dresser GK, Spence JD, Bailey DG (2000) Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 38:41\u201357","journal-title":"Clin Pharmacokinet"},{"key":"215_CR8","unstructured":"FDA (2006) Guidance for industry: drug interaction studies \u2013 study design, data analysis, and implications for dosing and labeling (draft guidance). http:\/\/www.fda.gov\/OHRMS\/DOCKETS\/98fr\/06d-0344-gdl0001.pdf . Accessed 7 Feb 2013"},{"key":"215_CR9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/0002-9378(90)90550-Q","volume":"163","author":"JW Goldzieher","year":"1990","unstructured":"Goldzieher JW, Brody SA (1990) Pharmacokinetics of ethinyl estradiol and mestranol. Am J Obstet Gynecol 163:2114\u20132119","journal-title":"Am J Obstet Gynecol"},{"key":"215_CR10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1021\/tx00016a015","volume":"3","author":"FP Guengerich","year":"1990","unstructured":"Guengerich FP (1990) Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem Res Toxicol 3:363\u2013371","journal-title":"Chem Res Toxicol"},{"key":"215_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13625180400008940","volume":"9","author":"D Heger-Mahn","year":"2004","unstructured":"Heger-Mahn D, Warlimont C, Faustmann T, Gerlinger C, Klipping C (2004) Combined ethinylestradiol\/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers. Eur J Contracept Reprod Health Care 9:173\u2013181","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"215_CR12","unstructured":"Janssen-Cilag (2012) Evra\u00ae transdermal patch. Summary of product characteristics"},{"key":"215_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0010-7824(90)90050-6","volume":"42","author":"C Jung-Hoffmann","year":"1990","unstructured":"Jung-Hoffmann C, Kuhl H (1990) Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedings. Contraception 42:423\u2013438","journal-title":"Contraception"},{"issue":"Suppl 1","key":"215_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","volume":"8","author":"H Kuhl","year":"2005","unstructured":"Kuhl H (2005) Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 8(Suppl 1):3\u201363. doi: 10.1080\/13697130500148875","journal-title":"Climacteric"},{"key":"215_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0773.2003.t01-1-930202_93_2.x","volume":"93","author":"K Laine","year":"2003","unstructured":"Laine K, Yasar U, Widen J, Tybring G (2003) A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes. Pharmacol Toxicol 93:77\u201381. doi: 10.1034\/j.1600-0773.2003.t01-1-930202_93_2.x","journal-title":"Pharmacol Toxicol"},{"key":"215_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2006.02762.x","volume":"63","author":"N Nassr","year":"2007","unstructured":"Nassr N, Lahu G, von Richter O, Reutter F, Knoerzer D, Zech K, Erb KA, Schug B, Blume H, Hermann R (2007) Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects. Br J Clin Pharmacol 63:365\u2013370. doi: 10.1111\/j.1365-2125.2006.02762.x","journal-title":"Br J Clin Pharmacol"},{"key":"215_CR18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/clpt.1993.25","volume":"53","author":"KT Olkkola","year":"1993","unstructured":"Olkkola KT, Aranko K, Luurila H, Hiller A, Saarnivaara L, Himberg JJ, Neuvonen PJ (1993) A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 53:298\u2013305","journal-title":"Clin Pharmacol Ther"},{"key":"215_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2125.2000.00271.x","volume":"50","author":"S Palovaara","year":"2000","unstructured":"Palovaara S, Kivisto KT, Tapanainen P, Manninen P, Neuvonen PJ, Laine K (2000) Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1\u2032-hydroxylation. Br J Clin Pharmacol 50:333\u2013337. doi: 10.1046\/j.1365-2125.2000.00271.x","journal-title":"Br J Clin Pharmacol"},{"key":"215_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0002-9378(98)80016-1","volume":"178","author":"FE Sinofsky","year":"1998","unstructured":"Sinofsky FE, Pasquale SA (1998) The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. Am J Obstet Gynecol 178:300\u2013304","journal-title":"Am J Obstet Gynecol"},{"key":"215_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1020072325818","volume":"3","author":"FZ Stanczyk","year":"2002","unstructured":"Stanczyk FZ (2002) Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Rev Endocr Metab Disord 3:211\u2013224","journal-title":"Rev Endocr Metab Disord"},{"key":"215_CR22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","volume":"38","author":"KE Thummel","year":"1998","unstructured":"Thummel KE, Wilkinson GR (1998) In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol 38:389\u2013430. doi: 10.1146\/annurev.pharmtox.38.1.389","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"215_CR23","unstructured":"UN Department of Economic and Social Affairs Population Division (2011) World contraceptive use. http:\/\/www.un.org\/esa\/population\/publications\/contraceptive2011\/contraceptive2011.htm . Accessed 5 Dec 2012"},{"key":"215_CR24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2165\/00003495-199550020-00010","volume":"50","author":"MI Wilde","year":"1995","unstructured":"Wilde MI, Balfour JA (1995) Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations. Drugs 50:364\u2013395","journal-title":"Drugs"},{"key":"215_CR25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00003088-200544030-00005","volume":"44","author":"S Zhou","year":"2005","unstructured":"Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL (2005) Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44:279\u2013304","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-014-0215-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-014-0215-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-014-0215-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:37Z","timestamp":1559490277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-014-0215-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,6]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s13318-014-0215-8","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,6]]}}}